article thumbnail

Bayer Expands Collaboration with Tsinghua University to Boost Pharma R&D in China

The Pharma Data

In just three years, nine promising research projects have received funding under the program, setting the stage for innovative breakthroughs in drug discovery. This program was specifically designed to support early-stage scientific research with high translational potential.

article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). So what about the theoretical basis for the claim that AI can “revolutionise” drug discovery and development?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mapping the GenAI Landscape in Pharma R&D

BenchSci

While we have made tremendous progress in drug discovery over the last couple of decades, the process of discovering new drugs is time-consuming, intricate, and costly. Today, the pharmaceutical (pharma) industry is in the midst of a transformative era driven by the advent of Generative AI (GenAI).

article thumbnail

Building the Disease Biology Generative AI Platform for Pharma R&D

BenchSci

Earlier this month, I traveled across North America and the UK to meet our 340 team members. Every year in January, we kick off the year with our “Roadshow”, where I meet our team in person and share our accomplishments and learning from the previous year and where we are going next.

article thumbnail

AI Drug Discovery: Revolutionizing Pharma R&D with Artificial Intelligence

Crown Bioscience

AI: Amplifying Efficiency in Drug Discovery The traditional drug discovery process has long been known for its high costs and low efficiency. Companies like Crown Bioscience are at the forefront, utilizing AI to compress the timeline for drug development from years to months.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.